4.7 Article

Predicting Phospholipidosis Using Machine Learning

Journal

MOLECULAR PHARMACEUTICS
Volume 7, Issue 5, Pages 1708-1714

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/mp100103e

Keywords

Phospholipidosis; machine learning; Random Forest; Support Vector Machine; in silico; prediction

Funding

  1. EPSRC [EP/F049102/1]
  2. Scottish Universities Life Sciences Alliance (SULSA)
  3. EPSRC [EP/F049102/1] Funding Source: UKRI
  4. Engineering and Physical Sciences Research Council [EP/F049102/1] Funding Source: researchfish

Ask authors/readers for more resources

Phospholipidosis is an adverse effect caused by numerous cationic amphiphilic drugs and can affect many cell types. It is characterized by the excess accumulation of phospholipids and is most reliably identified by electron microscopy of cells revealing the presence of lamellar inclusion bodies. The development of phospholipidosis can cause a delay in the drug development process, and the importance of computational approaches to the problem has been well documented. Previous work on predictive methods for phospholipidosis showed that state of the art machine learning methods produced the best results. Here we extend this work by looking at a larger data set mined from the literature. We find that circular fingerprints lead to better models than either E-Dragon descriptors or a combination of the two. We also observe very similar performance in general between Random Forest and Support Vector Machine models.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available